Drawing for SECOND SCREEN

USPTO serial 97570693

SECOND SCREEN

Reviewed by CopyMark Law Group

Reg. 7976984Status 700Registered
Filing date
Status date
Registration date
Oct 7, 2025
Examiner
GRIFFITHS, SYDNEY V
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SECOND SCREEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ashley N. Klein

Ashley N. Klein Bradley Arant Boult Cummings LLP1230 Peachtree Street NE, Suite 2100Promenade TowerAtlanta, GA 30309

Goods and services

ClassDescriptionStatusFirst use
042Software as a Service (SAAS) services featuring software for use by pharmacies and their patients, namely, business management software; Software as a Service (SAAS) services featuring software for use by pharmacies and their patients, namely, software for communicating and recording both asynchronously and in real-time via various communication channels including Short Message Service (SMS), email, voice, and secure in-app; Software as a Service (SAAS) services featuring software for use by pharmacies and their patients, namely, software for managing prescriptions, prescription refill ordering, providing medication synchronization, managing appointments, improving adherence, providing proactive healthcare, providing digital content including health education in various formats including video, providing secondary insurance, discounts and coupons, providing payment processing for both e-commerce and in-store purchasers, managing and executing tasks and workflows, providing Interactive Voice Response (IVR) capabilities, digital marketing, managing forms and surveys, automation, reporting, benchmarking, auditing, logging, managing loyalty programs, and providing recommendations; Software as a Service (SAAS) services featuring software for use by pharmacies for managing and growing their businesses; Software as a Service (SAAS) services featuring software for website and mobile application development; Software as a Service (SAAS) services featuring software for website and mobile application development, namely, software for use by pharmacies and their patients to create, maintain, and manage websites and mobile software applications that provide health and medication information, discounts and coupons, prescription refill ordering, waitlist registrations, health news resources, the ability to sign up for clinical trials, send messages, manage digital marketing campaigns, and view metrics and reports; Software as a Service (SAAS) services featuring software for use by pharmacies to send 2-way messages to their patients, schedule appointments, create and deliver electronic newsletters and social media content in the field of health and medications; Software as a Service (SAAS) services featuring software for patient engagement, namely, real-time conversations, task-based work flows, and clinical opportunity management; Software as a Service (SAAS) services featuring software for digital marketing, namely, creating targeted advertising, social media content, and branded graphics and videos; Software as a Service (SAAS) services featuring software for use by pharmacies, namely, software for providing interactive wellness classes; Software as a Service (SAAS) services featuring software for use in providing customer interaction management; Software as a Service (SAAS) services featuring software for use in providing call center communications, operations, and management; Software as a Service (SAAS) services featuring software for use in providing call center and telecommunications functionality, namely, predictive dialing, call recording, call reporting, voicemail archiving, voice recognition, interactive voice response systems, and interactive transaction processing systems; Software as a Service (SAAS) services featuring software for payment processing; Software as a Service (SAAS) services featuring business management software for use in the e-commerce industry; Software as a Service (SAAS) services featuring software for use by pharmacies to create, maintain, and manage websites and mobile software applications that provide health and medication information, discounts and coupons, prescription refill ordering, and the ability to sign-up for clinical trials; software as a service (SAAS) services featuring software for use by pharmacies to create and deliver electronic newsletters and social media content in the field of health and medicationsACTIVEJun 3, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 7, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 3, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Sep 15, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 15, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 8, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 8, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 13, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 13, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 16, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 11, 2024IUAFUSE AMENDMENT FILED—
Jun 11, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 11, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 11, 2024EX1GSOU EXTENSION 1 GRANTED—
Jun 11, 2024EXT1SOU EXTENSION 1 FILED—
Jun 11, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 12, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 21, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 27, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 8, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 8, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Jun 8, 2023CNSLSUSPENSION LETTER WRITTEN—
Jun 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 7, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 21, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2023DOCKASSIGNED TO EXAMINER—
Sep 17, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 2, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance